Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Operating activities      
Net loss $ (87,280) $ (221,962)  
Adjustments to reconcile net loss to net cash used in operations      
Amortization of debt discount 2,835 4,558 $ 2,835
Accreted interest on note receivable (3,308)  
Net loss from equity method investment 5,541  
Unrealized (gain) loss on available - for - sale securities (5,315) 131,535  
Decrease (Increase) in      
Accounts receivable – related party 45,000 (22,500)  
Interest receivable (4,216)  
Increase in      
Accounts payable and accrued expenses 30,514 66,078  
Accounts payable and accrued expenses - related party 30,000  
Accumulated losses on unconsolidated investees in excess of investment 613  
Net cash used in operating activities (14,246) (13,661)  
Net decrease in cash (14,246) (13,661)  
Cash and cash equivalents - beginning of period 235,311 227,558 227,558
Cash and cash equivalents - end of period 221,065 213,897 $ 235,311
Supplemental disclosure of cash flow information      
Cash paid for interest  
Cash paid for income tax  
Supplemental disclosure of non-cash investing and financing activities      
Investment at fair value received from issuance of note receivable